Gupta Shalabh K. 4
4 · Unicycive Therapeutics, Inc. · Filed Nov 23, 2022
Insider Transaction Report
Form 4
Gupta Shalabh K.
DirectorCEO
Transactions
- Award
Stock Options
2022-11-21+86,000→ 202,279 totalExercise: $0.75Exp: 2032-11-21→ Common Stock (86,000 underlying)
Footnotes (1)
- [F1]21,500 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.